The abstract is read at the publisher; the summary is JClub's.
In 15 healthy adults with desmopressin- and water-loading–induced hyponatremia, neither high-dose (1800 nmol) nor low-dose (180 nmol) intravenous [Pyr¹]apelin-13 increased cumulative urine output versus placebo.
- Why it matters: Apelin antagonizes arginine vasopressin and boosts urine output in hyponatremic rodent models, but human evidence for apelin analogues was missing.
- What they did: In a double-blind, randomized, placebo-controlled crossover design, participants received 3-hour infusions of [Pyr¹]apelin-13 (1800 nmol or 180 nmol) or placebo, after inducing an artificial syndrome of inappropriate antidiuresis.
- The result: Cumulative urine output from infusion start through 1 hour after completion showed no clinically relevant difference for either apelin dose compared with placebo, limiting support for acute diuretic effects in this setting.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.